ArticleScientific reports2025
Green synthesis of iron and zinc nanoparticles, total phenolic and total flavonoid components, and pharmacological studies of Perovskia atriplicifolia Benth.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Perovskia atriplicifolia Benth. commonly known as Russian sage, is an important ornamental and medicinal plant native to Himalayas and western China. In traditional medicine, it has been used in the treatment of various diseases such as stomach pain, indigestion, fever, dysentery and in various bacterial infections. This study investigated the green synthesis of iron and zinc nanoparticles, phytochemicals, and biological evaluation of P. atriplicifolia with emphasis on its therapeutic potentials. The characterization of nanoparticles was performed through SEM, XRD, FT-IR and UV. The activities, including cytotoxicity, thrombolytic, antibacterial, and anti-Inflammatory, were conducted on the different polarity extracts of P. atriplicifolia and nanoparticles. Among all, ethyl acetate extract (PAE), dichloromethane extract (PAD), and Zn-NPs were shown to have significant results. Total phenolic content (TPC) and total flavonoid content (TFC) in the crude extract were 258.96 mg GAE/g and 511.71 mg CE/g, respectively. In vitro studies have shown that P. atriplicifolia possesses significant biological potentials that encourage its traditional medicinal uses. Based on these findings, it can be exploited in the development of various therapeutic products. However, there is a dire need for systematic examination in clinical trials to determine the safe dosage and efficacy of P. atriplicifolia for the treatment of several disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.